Post Reply
821-840 of 10899
Friend Starlene, Biosensors hit 1.40! Your 500 lots are raking in $100,000 profit! Are you going to take it or wait till 1.62?
Wah! you are one successful trader. You are my shining star!
finally return to 1.40 level
Beautiful!
Happy to see buddies make $$$ here.
ride the trend, protect your profit!!
Take profit ,$ in the bank first, pull back n enter is the best strategy!
Starlene, got good thing no share with me... Buddy buddy in bio mah at least haaaa
Anw u all think this ride will last how long? Full comerciallise in 2014 leh
I Huat lor ! Thank you!
yiming 2000,U got my PM..money making $$$-sure win b4 I made public..congras..$1.37 Biosensor
Good play and congrats !
bishan22 ( Date: 29-Jan-2013 09:24) Posted:
Now riding on strong wave. Good luck. 
bishan22 ( Date: 24-Jan-2013 16:13) Posted:
|
Hop in today. Cleared 1.25 should be in bullish trend. Good luck. |
|
|
|
Now riding on strong wave. Good luck.
bishan22 ( Date: 24-Jan-2013 16:13) Posted:
|
Hop in today. Cleared 1.25 should be in bullish trend. Good luck. |
|
Not sure how far it can go. I took profit as it has reached (exceeded) my target selling price.
Good luck to all !
It appears to me some parties already know about the announcement before hand, and that explained why they were buying this stock from 1.22 -----> 1.32.
Possible?
No wonder Biosensor breaks $1.25 and hit $1.34 before close at $1.33
raykee ( Date: 28-Jan-2013 21:40) Posted:
for all my buddies
Biosensors Receives CE Mark Approval for BioFreedom™
Singapore, 28 January 2013 – Biosensors International Group, Ltd. (“Biosensors” or the “Company”,
Bloomberg: BIG SP Reuters: BIOS.SI SGX: B20), a developer, manufacturer and marketer of
innovative medical devices, today announced CE Mark approval for its polymer-free drug-coated
stent (DCS), BioFreedom™.
BioFreedom represents the latest development in Biosensors’ stent technology, featuring a microstructured abluminal surface which permits the controlled release of Biolimus A9™ (BA9™) without
the use of a polymer. BA9 is a highly lipophilic anti-restenotic drug developed by Biosensors
specifically for use with stents.
CE Mark approval for BioFreedom was supported by strong data from the BioFreedom First in Man
study. In this study BioFreedom was compared to Boston Scientific’s Taxus™ Liberté™ drug-eluting
stent (DES). At 12 months, BioFreedom demonstrated equivalent efficacy, measured by in-stent late
lumen loss, compared with Taxus Liberté, with a trend towards superiority. Median in-stent late
lumen loss in patients receiving BioFreedom was reduced to 0.17 mm as compared with a median instent late lumen loss of 0.35 mm in the Taxus Liberté group. Three year clinical results, presented at
the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in October 2012, showed
similar rates of MACE (Major Adverse Cardiac Events) between BioFreedom and Taxus Liberté, with
no evidence of stent thrombosis in either group.
To further evaluate BioFreedom in a larger patient population, Biosensors recently announced
initiation of enrolment in LEADERS FREE, the world’s first prospective, randomised double-blind trial
between a DCS and bare-metal stent (BMS), exclusively involving patients at high risk of bleeding.
The study has been designed to confirm that BioFreedom is as safe as a BMS in this patient group,
and can deliver the anti-restenotic benefit of a DES, with only a one-month course of dual antiplatelet therapy administered to all patients.
This trial will provide additional data to support the launch of BioFreedom in select markets during
2013. The full commercial launch is currently anticipated during 2014. |
|
great !!! finally got the approval....congrats to those who are vested.
for all my buddies
Biosensors Receives CE Mark Approval for BioFreedom™
Singapore, 28 January 2013 – Biosensors International Group, Ltd. (“Biosensors” or the “Company”,
Bloomberg: BIG SP Reuters: BIOS.SI SGX: B20), a developer, manufacturer and marketer of
innovative medical devices, today announced CE Mark approval for its polymer-free drug-coated
stent (DCS), BioFreedom™.
BioFreedom represents the latest development in Biosensors’ stent technology, featuring a microstructured abluminal surface which permits the controlled release of Biolimus A9™ (BA9™) without
the use of a polymer. BA9 is a highly lipophilic anti-restenotic drug developed by Biosensors
specifically for use with stents.
CE Mark approval for BioFreedom was supported by strong data from the BioFreedom First in Man
study. In this study BioFreedom was compared to Boston Scientific’s Taxus™ Liberté™ drug-eluting
stent (DES). At 12 months, BioFreedom demonstrated equivalent efficacy, measured by in-stent late
lumen loss, compared with Taxus Liberté, with a trend towards superiority. Median in-stent late
lumen loss in patients receiving BioFreedom was reduced to 0.17 mm as compared with a median instent late lumen loss of 0.35 mm in the Taxus Liberté group. Three year clinical results, presented at
the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in October 2012, showed
similar rates of MACE (Major Adverse Cardiac Events) between BioFreedom and Taxus Liberté, with
no evidence of stent thrombosis in either group.
To further evaluate BioFreedom in a larger patient population, Biosensors recently announced
initiation of enrolment in LEADERS FREE, the world’s first prospective, randomised double-blind trial
between a DCS and bare-metal stent (BMS), exclusively involving patients at high risk of bleeding.
The study has been designed to confirm that BioFreedom is as safe as a BMS in this patient group,
and can deliver the anti-restenotic benefit of a DES, with only a one-month course of dual antiplatelet therapy administered to all patients.
This trial will provide additional data to support the launch of BioFreedom in select markets during
2013. The full commercial launch is currently anticipated during 2014.
Must hve discipline,,penny stocks need 1 -2 cts will more than break even,and even a 5-10cts can make a lot of money..hot inflow of funds still coming into Asean mkts..but remeember to get out fast once the tide turn against you..time to make $$$ now..I have 3millions of JES bought from 14-17cts and I took some profits when it was 19-20.5cts,not too worry still hve some upside..always go for those stocks U hve make $$$ before..JES I previously sold off 35-38cts and make good profits ,hence now playing with my profits and am prepared to lose too,but cut when the need arises,never ,never hesistate,evn if it lost one arm still has the other arm-motto:noone ever dies from taking profits but many died from failure to take profits
yiming2000 ( Date: 28-Jan-2013 15:12) Posted:
Friend Starlene, you have already made more than $30k on Maxi-cash which is trading 0.445 now. Buying after ex-bonus at 0.39 is very clever. I am definitely going to watch Maxi-Cash for entry point. Why are you so brave? Trading like BB with 500 and 1000 lots? Aren't you scared? What other counters are you vested or watching? I need to go big like you.
|
|
Friend Starlene, you have already made more than $30k on Maxi-cash which is trading 0.445 now. Buying after ex-bonus at 0.39 is very clever. I am definitely going to watch Maxi-Cash for entry point. Why are you so brave? Trading like BB with 500 and 1000 lots? Aren't you scared? What other counters are you vested or watching? I need to go big like you.
Ang pow coming! Results will show!!!
[/color]
